Related Experiment Video
Updated: Jun 25, 2026
05:59
High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Sleepiness or excessive daytime somnolence.
Ethel Mitty Edd1, Sandi Flores
1College of Nursing, New York University, John A. Hartford Institute for Geriatric Nursing, New York University, New York, NY, USA.
Geriatric Nursing (New York, N.Y.)
|February 14, 2009
Summary
Excessive daytime somnolence (EDS) and insomnia are common in older adults, impacting sleep architecture and quality of life. Early assessment and diverse treatments, including sleep hygiene, are crucial for managing these conditions.
Area of Science:
- Gerontology
- Sleep Medicine
- Neurology
Background:
- Excessive daytime somnolence (EDS) and insomnia are prevalent in older adults, linked to aging, lifestyle, and comorbidities.
- Sleep architecture, encompassing REM and non-REM stages, is regulated by circadian rhythms and disrupted by insomnia.
- Insomnia is associated with numerous health issues, including dementia, cardiovascular disease, and neurological disorders.
Purpose of the Study:
- To review the causes and consequences of excessive daytime somnolence and insomnia in older adults.
- To highlight the importance of recognizing and treating sleep disruption in this population.
- To discuss assessment methods and available treatment options for sleep disorders.
Main Methods:
- Literature review of factors contributing to EDS and insomnia.
- Analysis of the impact of sleep disruption on health and quality of life.
- Overview of diagnostic tools and therapeutic interventions for sleep disorders.
Main Results:
- EDS and insomnia stem from various factors including age-related changes, circadian rhythm disorders, and comorbidities.
- Sleep disruption negatively affects cognitive function, physical performance, and overall well-being, increasing fall risk.
- Sleep disorders in older adults are often underdiagnosed and undertreated, despite available assessment and treatment options.
Conclusions:
- Effective management of EDS and insomnia in older adults requires prompt recognition and a multimodal treatment approach.
- Interventions range from sleep hygiene education to pharmacological and alternative therapies.
- Addressing sleep disturbances is essential for improving health outcomes and quality of life in the aging population.
Related Concept Videos
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
01:17Sleepwalking and Sleep Talking
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:21Sleep Apnea
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...